ICD-10 Coding for Congenital Hypertrophy of Retinal Pigment Epithelium(C69.32, C69.32U, D12.6)
Learn about the ICD-10 coding for Congenital Hypertrophy of Retinal Pigment Epithelium (CHRPE), including its association with Familial Adenomatous Polyposis (FAP).
Complete code families applicable to Congenital Hypertrophy of Retinal Pigment Epithelium
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| Q14.1 | Congenital malformation of retina | Use for any presentation of CHRPE unless specifically linked to FAP. |
|
| D12.6 | Adenomatous polyposis of colon | Use when CHRPE is part of a clinical picture of FAP. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutCongenital Hypertrophy of Retinal Pigment Epithelium
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Congenital Hypertrophy of Retinal Pigment Epithelium.
Omitting family history of FAP
Impact
Clinical: Missed opportunity for genetic counseling, Regulatory: Non-compliance with hereditary condition documentation, Financial: Potential loss of reimbursement for related services
Mitigation
Always inquire about family history during patient intake
Using Q14.1 alone when FAP is present
Impact
Reimbursement: Potential underpayment due to incomplete coding, Compliance: Non-compliance with coding guidelines for hereditary conditions, Data Quality: Inaccurate representation of patient's clinical picture
Mitigation
Include D12.6 when CHRPE is associated with FAP.
Incomplete coding of hereditary conditions
Impact
Failure to include all relevant codes for conditions like FAP.
Mitigation
Implement regular training on hereditary condition coding.